日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

PDZK1 suppresses TNBC development and sensitizes TNBC cells to erlotinib via the EGFR pathway

PDZK1 通过 EGFR 通路抑制 TNBC 发展并增强 TNBC 细胞对厄洛替尼的敏感性

Yuanzhen Ma #, Zhiyu Fang #, Hongning Zhang #, Yijun Qi, Yuke Mao, Junfang Zheng

Risk of subsequent primary cancers in bladder cancer survivors

膀胱癌幸存者罹患后续原发性癌症的风险

Guo, Yadong; Zhang, Yuke; Mao, Shiyu; Zhang, Wentao; Yang, Fuhan; Wang, Ruiliang; Chen, Haotian; Zhang, Aihong; Yao, Xudong